Babies at risk for neonatal sepsis are too young to be immunized, so Alloy-EK would be administered to expectant mothers to protect their infants. Administering the vaccine to pregnant mothers may simultaneously reduce the risk of infections in mothers that are caused by the same bacteria.
Current Development Stage: Lead Optimization
CARB-X Investment: US$1.7 million
Initial CARB-X Investment Date: January 18, 2024
Current Development Stage: Lead Optimization
CARB-X Investment: US$1.7 million
Initial CARB-X Investment Date: January 18, 2024
Location: United States, Minnesota, Saint Paul
Investors 1
| Date | Name | Website |
| 09.02.2024 | CARB-X | carb-x.org |
Mentions in press and media 2
| Date | Title | Description |
| 16.12.2009 | Syntiron scores major vaccine deal with Sanofi Pasteur | Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| - | Syntiron scores major vaccine deal with Sanofi Pasteur | ST. PAUL, Minnesota–Syntiron LLC, a biotech start-up, has signed a $149 million licensing deal with Sanofi Pasteur in Lyon, France to develop a vaccine against so-called “super bugs,” bacteria that have become resistant to antibiotics. Unde... |